BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37532540)

  • 1. Toceranib phosphate and firocoxib-mediated partial response in a dog with advanced intranasal sarcoma.
    Osada H; Okazawa T; Kushida K; Kishimoto M; Ikeda M; Kondo H; Kimura J; Ohmori K
    J Vet Med Sci; 2023 Sep; 85(9):1004-1009. PubMed ID: 37532540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A canine case of malignant melanoma carrying a KIT c.1725_1733del mutation treated with toceranib: a case report and in vitro analysis.
    Tani H; Miyamoto R; Noguchi S; Kurita S; Nagashima T; Michishita M; Yayoshi N; Tamura K; Bonkobara M
    BMC Vet Res; 2021 Apr; 17(1):147. PubMed ID: 33827546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs.
    Yamazaki H; Miura N; Lai YC; Takahashi M; Goto-Koshino Y; Yasuyuki M; Nakaichi M; Tsujimoto H; Setoguchi A; Endo Y
    J Vet Med Sci; 2017 Jul; 79(7):1225-1229. PubMed ID: 28592719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report.
    Fuertes-Recuero M; Vázquez-Fernández E; Lizasoain-Sánz G; Arroba-Alonso A; Sánchez-López A; Martínez-de-Merlo E; Suárez-Redondo M; Ortiz-Diez G
    Vet Res Commun; 2024 Jun; 48(3):1921-1927. PubMed ID: 38453822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evaluation of serial (18) FDG-PET/CT to assess response to toceranib phosphate therapy in canine cancer.
    Leblanc AK; Miller AN; Galyon GD; Moyers TD; Long MJ; Stuckey AC; Wall JS; Morandi F
    Vet Radiol Ultrasound; 2012; 53(3):348-57. PubMed ID: 22360684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excision.
    London CA; Malpas PB; Wood-Follis SL; Boucher JF; Rusk AW; Rosenberg MP; Henry CJ; Mitchener KL; Klein MK; Hintermeister JG; Bergman PJ; Couto GC; Mauldin GN; Michels GM
    Clin Cancer Res; 2009 Jun; 15(11):3856-65. PubMed ID: 19470739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs.
    Yamazaki H; Tanaka T; Mie K; Nishida H; Miura N; Akiyoshi H
    J Vet Intern Med; 2020 May; 34(3):1272-1281. PubMed ID: 32267594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of tumor enhancement by contrast-enhanced CT in solid tumor-bearing dogs treated with toceranib phosphate.
    Takagi S; Yamazaki H; Izumi Y; Hanazono K; Hoshino Y; Hosoya K
    Vet Radiol Ultrasound; 2020 Jul; 61(4):427-434. PubMed ID: 32162400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
    Gustafson TL; Biller B
    J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
    Urie BK; Russell DS; Kisseberth WC; London CA
    BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
    Musser ML; Johannes CM
    BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
    Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
    Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
    Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
    J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate.
    Ichimata M; Nishiyama S; Matsuyama F; Fukazawa E; Harada K; Katayama R; Toshima A; Kagawa Y; Yamagami T; Kobayashi T
    J Vet Med Sci; 2021 Oct; 83(10):1554-1558. PubMed ID: 34408099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toceranib phosphate-associated nephrotic syndrome in a dog: a case report.
    Remerowski SM; Herrera CL; Donnelly LL
    BMC Vet Res; 2021 Apr; 17(1):146. PubMed ID: 33827545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines.
    Korec DI; Louke DS; Breitbach JT; Geisler JA; Husbands BD; Fenger JM
    BMC Vet Res; 2021 Oct; 17(1):320. PubMed ID: 34600548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma.
    Rippy SB; Gardner HL; Nguyen SM; Warry EE; Portela RA; Drost WT; Hostnik ET; Green EM; Chew DJ; Peng J; London CA
    BMC Vet Res; 2016 Nov; 12(1):257. PubMed ID: 27855679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.